Harbourvest Partners’s NextCure NXTC Stock Holding History

Harbourvest Partners’s Portfolio NXTC Stock Details NXTC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-837	Closed	-$13.8K	–	29
2024 Q3	$13.8K	Hold	837	–	–	0.01%	34
2024 Q2	$16K	Hold	837	–	–	0.01%	38
2024 Q1	$22.4K	Hold	837	–	–	0.01%	45
2023 Q4	$11.4K	Hold	837	–	–	﹤0.01%	53
2023 Q3	$13K	Hold	837	–	–	﹤0.01%	58
2023 Q2	$18.1K	Hold	837	–	–	0.01%	58
2023 Q1	$14.9K	Hold	837	–	–	0.01%	63
2022 Q4	$14.2K	Hold	837	–	–	﹤0.01%	65
2022 Q3	$28K	Hold	837	–	–	0.01%	66
2022 Q2	$47K	Hold	837	–	–	0.02%	61
2022 Q1	$49K	Hold	837	–	–	0.01%	65
2021 Q4	$60K	Hold	837	–	–	0.01%	66
2021 Q3	$68K	Hold	837	–	–	0.01%	56
2021 Q2	$81K	Hold	837	–	–	0.01%	49
2021 Q1	$101K	Hold	837	–	–	0.01%	41
2020 Q4	$109K	Hold	837	–	–	0.04%	24
2020 Q3	$88K	Hold	837	–	–	0.03%	33
2020 Q2	$215K	Hold	837	–	–	0.09%	26
2020 Q1	$372K	Buy	+837	New	+$447K	0.18%	29

Other funds holding NXTC

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

Pfizer New York $239M AUM 232.47% 1-Year Est. Return

AAA

Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

CCC

Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Harbourvest Partners's NXTC Position: Q4 2024 in Review

Harbourvest Partners sold out of NextCure (NXTC) in Q4 2024, closing a stake of 837 shares — an estimated $13.8K sold.

Harbourvest Partners first reported a position in NXTC in Q1 2020 and held it in 19 quarters. The position peaked at $372K in Q1 2020. 45 funds tracked by Wall St. Rank hold NXTC as of Q4 2024.

Harbourvest Partners reported no remaining NextCure position as of Q4 2024 after selling out during the quarter.
Harbourvest Partners sold 837 NextCure shares in Q4 2024, an estimated $13.8K.
Harbourvest Partners first reported a position in NextCure in Q1 2020 and held it in 19 quarters.
Harbourvest Partners's NextCure position peaked at $372K in Q1 2020.
45 funds tracked by Wall St. Rank held NextCure as of Q4 2024.

Based on Harbourvest Partners's 13F filing for Q4 2024, filed 14 Feb 2025.